AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies
July 28, 2023 at 11:00 AM EDT
Stock gains 5% after AstraZeneca's second-quarter results top analyst expectations.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|